Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Geary

Showing results (21-30 of 152) with videos related to

Pageof 16
Sort By:
Clinical Pharmacokinetics|January 7, 2015
Clinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro(®)): a second-generation antisense oligonucleotide inhibitor of apolipoprotein BRichard S Geary, Brenda F Baker, Stanley T Crooke
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1989
Insulin-like growth factor-I is internalized after binding to the type I insulin-like growth factor receptorE S Geary, R G Rosenfeld, A R Hoffman
Applied Nursing Research : ANR|August 1, 1992
Preoperative self-efficacy and postoperative behaviorsS L Oetker-Black, F Hart, J Hoffman, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 31, 2019
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc<sub>3</sub>-Conjugated Antisense OligonucleotidesYanfeng Wang, Rosie Z Yu, Scott Henry, et al.
Pharmacological Research|August 11, 1998
Bioavailability of intranasal promethazine dosage forms in dogsR Ramanathan, R S Geary, D W Bourne, et al.
Advanced Drug Delivery Reviews|February 11, 2015
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotidesRichard S Geary, Daniel Norris, Rosie Yu, et al.
American Clinical Laboratory|March 9, 1995
The determination of free urinary catecholamines using LCECV M Abate, G W Overdorf, T Huang, et al.
Global Health Action|January 28, 2015
Evaluating youth-friendly health services: young people's perspectives from a simulated client study in urban South AfricaRebecca S Geary, Emily L Webb, Lynda Clarke, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|March 14, 2002
Drug properties of second-generation antisense oligonucleotides: how do they measure up to their predecessors?S P Henry, R S Geary, R Yu, et al.
The Journal of Urology|July 1, 1995
Nerve sparing radical prostatectomy: a different viewE S Geary, T E Dendinger, F S Freiha, et al.
Pageof 16

Showing results (21-30 of 152) with videos related to

Sort By:
Pageof 16
Clinical Pharmacokinetics|January 7, 2015
Clinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro(®)): a second-generation antisense oligonucleotide inhibitor of apolipoprotein BRichard S Geary, Brenda F Baker, Stanley T Crooke
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1989
Insulin-like growth factor-I is internalized after binding to the type I insulin-like growth factor receptorE S Geary, R G Rosenfeld, A R Hoffman
Applied Nursing Research : ANR|August 1, 1992
Preoperative self-efficacy and postoperative behaviorsS L Oetker-Black, F Hart, J Hoffman, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 31, 2019
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc<sub>3</sub>-Conjugated Antisense OligonucleotidesYanfeng Wang, Rosie Z Yu, Scott Henry, et al.
Pharmacological Research|August 11, 1998
Bioavailability of intranasal promethazine dosage forms in dogsR Ramanathan, R S Geary, D W Bourne, et al.
Advanced Drug Delivery Reviews|February 11, 2015
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotidesRichard S Geary, Daniel Norris, Rosie Yu, et al.
American Clinical Laboratory|March 9, 1995
The determination of free urinary catecholamines using LCECV M Abate, G W Overdorf, T Huang, et al.
Global Health Action|January 28, 2015
Evaluating youth-friendly health services: young people's perspectives from a simulated client study in urban South AfricaRebecca S Geary, Emily L Webb, Lynda Clarke, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|March 14, 2002
Drug properties of second-generation antisense oligonucleotides: how do they measure up to their predecessors?S P Henry, R S Geary, R Yu, et al.
The Journal of Urology|July 1, 1995
Nerve sparing radical prostatectomy: a different viewE S Geary, T E Dendinger, F S Freiha, et al.
Pageof 16